Pharmaceutical Contract Packaging: 5 Stages to a Successful Partnership

How PI Health Sciences Delivers Real-Time Visibility and Scientific Accountability

Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever

How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle S...

IPSC Manufacturing: From Dolly the Sheep to Clinical-Grade Cell Therapies

Agentic AI x Pharma Manufacturing: Interview with Matt Lowe, Chief Strategy Officer, MasterControl

Oral Solid Dosage Manufacturing: Inside Rottendorf Pharma’s Strategic Alliance With Corealis Pharma

5 reasons to attend CDMO Live Europe 2026

Combination Product Manufacturing: GLP-1 Hype, Talent Shortages, and the CDMO Shift

Novartis on What Great CDMO Partnerships Actually Look Like

Contract Packaging for Pharma: Questions to Ask Your CPO Partner Before You Sign

Eramol's Sterile Facility Targets ＞1% Material Loss for Biotech Clients

Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever

The Pharma Direct-to-Consumer Shift: Moving Faster Than Infrastructure Can Handle

How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform

Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever

Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models

Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models

Hybrid Synthesis is Redefining Peptide Manufacturing

The Case for Strategic CDMO Partnerships Over Multi-Sourcing

CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO

Trump's Most-Favored-Nation Policy Is Forcing Europe's Pharma Industry to Reconsider Its Pricing ...

The BMC: A Strategic Partner for the Biotechnology and Biopharmaceutical Industry

How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains

Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a ...

External Supply in a Volatile World: Advice for resilient supply chain with Ryan Kelly, Rx-360

How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Danie...

U.S. Vaccine Policy Shifts are Create a “Chilling” Effect on Global Manufacturing and Innovation

How Lifecore Injectables Bring Complex Solutions to Life: A 40-Year Track Record

Why Pharma Contract Negotiations Are Flawed and How to Fix Them

How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for C...

Digital Transparency Platform to be Launched by SGS CDMO Solutions

2026 US Pharma Outsourcing: Gil Roth on FDA Cuts, Pricing Pressures and CDMO Strategy

Reshoring Pressure vs. Manufacturing Reality: Report from ExM Leader Boston

Why Radiopharma Must Compete on Service Excellence – Not Clinical Data

Supply Chain Resilience Through Geographic Redundancy [Simtra BioPharma Solutions CEO]

How Integrated Drug Development and Manufacturing Creates Speed Advantage in Contract Pharma

How Charles River Helps Sponsors Accelerate Drug Development Through Strategic Testing

The Great Reshoring: US Captures 74% of CDMO Investment

ADC Manufacturing Demand Outpaces Capacity in US Market

Breaking the Death Spiral: How to Rescue Failing CDMO Relationships Before It’s Too Late

AI and Digital Maturity in Biopharma Contract Manufacturing

Markus Sieger Reflects on 25 Years Building Polpharma into Europe’s Generic Manufacturing Leader

CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities

What BioPlan's 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing

How Piramal Pharma Built a $1 Billion CDMO by Solving Client Problems, Not Selling Services

The End of Global Pharma Supply Chains: How Regionalization Will Impact Industry Profitability

How KBI Biopharma’s “Analytical Powerhouse” Underpins Their Full-Service CDMO Growth

Ardena CEO on Navigating CDMO Volatility: Specialization, Nanomedicine, and Resilience

Biotech Funding Strategies for European Companies

CDMO Live Europe 2026

Poland's Biotech Sector: From Emerging Market to Strategic Partner

How to Build True CDMOs-Biotech Partnerships

Inside Thermo Fisher’s Strategy for Analytical Services Growth

The New Pharma Playbook: External Manufacturing Interviews by PharmaSource

How Basel Became Europe’s Dynamic Biotech “Super Cluster”

Pharma Trends: A Commercial Perspective on Oncology, GLP-1 Expansion, and AI-Accelerated Development

MSD External Manufacturing: How Technical Operations are Driving Digital Innovation

Italy’s Biotech Future: How New Initiatives Are Breaking Down Growth Barriers

Building Investor-Ready CMC Programs: Marta Kijanka’s Strategic Framework for Early-Stage Biotechs